Endpoints News
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
Stay tuned for the rest of the day’s programming — you can still register for free to watch the live stream: events.endpoints.news/jpm26/regist...
Begin Registration
events.endpoints.news
January 12, 2026 at 6:11 PM
Stay tuned for the rest of the day’s programming — you can still register for free to watch the live stream: events.endpoints.news/jpm26/regist...
The pharmaceutical industry is slow by nature, Novo Nordisk CEO Mike Doustdar said at the Endpoints at #JPM26 event this morning. But he thinks it can get faster.
January 12, 2026 at 6:11 PM
The pharmaceutical industry is slow by nature, Novo Nordisk CEO Mike Doustdar said at the Endpoints at #JPM26 event this morning. But he thinks it can get faster.